Clinical Trials on Levercirros, gallvägar in Hong Kong
Totalt 770 resultat
-
The University of Hong KongOkändBiliär anastomotisk stenosHong Kong
-
The University of Hong KongResearch Grant CouncilRekryteringCirros | NAFLD | Kronisk hepatit b | Fibros, lever | Empagliflozin | SGLT2-hämmareHong Kong
-
Chinese University of Hong KongAvslutad
-
Chinese University of Hong KongIndragen
-
Chinese University of Hong KongRekrytering
-
Chinese University of Hong KongRekrytering
-
Chinese University of Hong KongAvslutad
-
The University of Hong KongAvslutadGastrit | Leverfibros | Pepticulcus sjukdom | KolangiopatiHong Kong
-
The University of Hong KongOkändPsoriasis | LeverfibrosHong Kong
-
Chinese University of Hong KongHar inte rekryterat ännu
-
Chinese University of Hong KongRekryteringMalign gallvägsobstruktionHong Kong
-
The University of Hong KongFood and Health Bureau, Hong KongAvslutadAlkoholfri fettleversjukdomHong Kong
-
Our Lady of Maryknoll HospitalWong Tai Sin HospitalOkändTrycksår Steg III | Trycksår, stadium IVHong Kong
-
Chinese University of Hong KongRekrytering
-
Chinese University of Hong KongRekryteringBekräftad diagnos av hepatocellulärt karcinom | Patienter som är planerade att genomgå transarteriell kemobolisering, systemisk terapikirurgi | Barns A till C cirrosHong Kong
-
Chinese University of Hong KongRekrytering
-
Chinese University of Hong KongRekryteringMetaboliskt syndrom | D-vitaminbrist | Nedsatt njurfunktion | HIV | Osteoporos | Osteopeni | LeverfibroserHong Kong
-
GenieBiome LimitedAvslutadIcke-alkoholisk fettleversjukdomHong Kong
-
Chinese University of Hong KongRekrytering
-
Humanity & Health Medical Group LimitedRekryteringHepatocellulärt karcinomHong Kong
-
Humanity and Health Research CentreRekryteringIcke-alkoholisk fettleversjukdom (NAFLD) | Icke-alkoholisk Steatohepatit (NASH)Hong Kong
-
The University of Hong KongOkändLever cancer | LevertransplantationsstörningHong Kong
-
Humanity & Health Medical Group LimitedBeijing 302 Hospital; Kindai University Faculty of MedicineAvslutadHepatocellulärt karcinomHong Kong
-
Chinese University of Hong KongRekrytering
-
Chinese University of Hong KongRekrytering
-
Humanity & Health Medical Group LimitedAvslutad
-
The University of Hong KongEducation University of Hong KongRekrytering
-
The University of Hong KongRekrytering
-
Chinese University of Hong KongRekryteringCholedocholithiasisHong Kong
-
The University of Hong KongAktiv, inte rekryterandeAlkoholfri fettleversjukdom | Bevis på levertransplantationHong Kong
-
The University of Hong KongRekrytering
-
Hoffmann-La RocheAvslutad
-
The University of Hong KongRekryteringFetma | Icke-alkoholisk fettleversjukdomHong Kong
-
Humanity & Health Medical Group LimitedIndragenKronisk leversjukdom | LeverkarcinomHong Kong
-
Chinese University of Hong KongRekrytering
-
The University of Hong KongAktiv, inte rekryterandeIcke-alkoholisk fettleversjukdom | Central fetmaHong Kong
-
Chinese University of Hong KongAktiv, inte rekryterandeDiabetes mellitus, typ 2 | Fettlever, alkoholfrittHong Kong
-
Chinese University of Hong KongRekryteringSömnapné, obstruktiv | Fet leverHong Kong
-
Chinese University of Hong KongHar inte rekryterat ännuIcke-alkoholisk fettleversjukdom (NAFLD) | Icke-alkoholisk Steatohepatit (NASH)Hong Kong
-
The University of Hong KongRekryteringHepatocellulärt karcinomHong Kong
-
Chinese University of Hong KongAvslutadHepatocellulärt karcinomHong Kong
-
Chinese University of Hong KongAvslutadHepatocellulärt karcinomHong Kong
-
Chinese University of Hong KongAvslutadHepatocellulärt karcinomHong Kong
-
Chinese University of Hong KongAvslutad
-
Bio-Cancer Treatment International LimitedThe University of Hong KongAvslutadHepatocellulärt karcinomHong Kong
-
Chinese University of Hong KongAvslutad
-
Dr Tan-to CHEUNGAvslutad
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong KongAvslutadHepatocellulärt karcinom | NeoplasmHong Kong
-
Humanity & Health Medical Group LimitedIndragenHCV-infektionHong Kong
-
Chinese University of Hong KongHealth and Medicine Research FundRekryteringHepatocellulärt karcinomHong Kong